cua cà mau cua tươi sống cua cà mau bao nhiêu 1kg giá cua hôm nay giá cua cà mau hôm nay cua thịt cà mau cua biển cua biển cà mau cách luộc cua cà mau cua gạch cua gạch cà mau vựa cua cà mau lẩu cua cà mau giá cua thịt cà mau hôm nay giá cua gạch cà mau giá cua gạch cách hấp cua cà mau cua cốm cà mau cua hấp mua cua cà mau cua ca mau ban cua ca mau cua cà mau giá rẻ cua biển tươi cuaganic cua cua thịt cà mau cua gạch cà mau cua cà mau gần đây hải sản cà mau cua gạch son cua đầy gạch giá rẻ các loại cua ở việt nam các loại cua biển ở việt nam cua ngon cua giá rẻ cua gia re crab farming crab farming cua cà mau cua cà mau cua tươi sống cua tươi sống cua cà mau bao nhiêu 1kg giá cua hôm nay giá cua cà mau hôm nay cua thịt cà mau cua biển cua biển cà mau cách luộc cua cà mau cua gạch cua gạch cà mau vựa cua cà mau lẩu cua cà mau giá cua thịt cà mau hôm nay giá cua gạch cà mau giá cua gạch cách hấp cua cà mau cua cốm cà mau cua hấp mua cua cà mau cua ca mau ban cua ca mau cua cà mau giá rẻ cua biển tươi cuaganic cua cua thịt cà mau cua gạch cà mau cua cà mau gần đây hải sản cà mau cua gạch son cua đầy gạch giá rẻ các loại cua ở việt nam các loại cua biển ở việt nam cua ngon cua giá rẻ cua gia re crab farming crab farming cua cà mau
Skip to main content

Sniffer dogs could detect COVID-19 days before symptoms occur

Scientists have discovered that dogs’ powerful sense of smell can enable the animal to sniff out COVID-19 on infected people even before they develop symptoms.

Recommended Videos

The global research efforts have so far led to two international airports deploying trained sniffer dogs in trials aimed at tracking down travelers with the virus as they pass through the facility.

Last month, Dubai’s main aviation hub became the first airport to use the canines in the vital role, with Finland’s main international airport in Helsinki also launching a trial in recent days.

While it’s already well documented that dogs can be trained to detect conditions such as cancer and diabetes, more research is needed to confirm the effectiveness of their ability to detect the coronavirus, with the current trials aiming to provide more data. However, the early signs are promising.

Speaking to Reuters about the Finnish effort, Anna Hielm-Bjorkman of the University of Helsinki said, “What we’ve seen in our research is that the dogs will find [COVID-19] five days before [the infected patient] gets any clinical symptoms,” adding that the clever canines are coming come close to a 100% success rate in detecting the virus, a figure confirmed by more conventional detection methods carried out later.

The trial involves a passenger wiping their neck with a piece of material before placing it inside a can. It’s then taken to another room where one of the dogs sets about giving it a noncontact sniff before offering a result conveyed though a trained response such as a bark.

The dog doesn’t sniff for the virus itself, but instead detects distinctive chemicals created by the body as it fights the virus.

A springer spaniel during training in the Adelaide research. Kelly Barnes/Getty Images

Researchers from the School of Animal and Veterinary Sciences at the University of Adelaide are also training sniffer dogs to detect COVID-19 in people. The dogs participating in the study are being trained to pick the positive COVID-19 sweat sample from a line-up of samples, using positive reinforcement — in this case time with their favorite toy — for each correct response. Initial results in the Australian test suggest some of the animals are recording a 100% success rate in identifying infected individuals, some of whom displayed no symptoms.

Similar research using dogs is also being carried out by teams in Germany, Spain, and Brazil.

Scientists involved in the research suggest the popular pet could be used not only at airports, but also hospitals, retirement homes, and quarantine facilities in the ongoing fight against the virus.

Drawbacks to using dogs for COVID-19 detection include the fact that it can take at least three months to train a new recruit, although canines with prior sniffing experience could be taught in less than a month. Also, while it’s known that conventional testing methods still fail to offer 100% reliability, a facility that chooses to use dogs to carry out sniff tests would have to be certain of each one’s reliability when it comes to identifying those infected with COVID-19.

If the research concludes that our four-legged friend is indeed an effective weapon against the virus, the procedure could join the other testing methods currently available.

Trevor Mogg
Contributing Editor
Not so many moons ago, Trevor moved from one tea-loving island nation that drives on the left (Britain) to another (Japan)…
FDA gives special authorization to speedy COVID-19 test
fda gives special authorization to speedy covid 19 test abbott laboratories binaxnow

The U.S. has received a boost in its efforts to conduct more COVID-19 tests after the Food and Drug Administration (FDA) granted emergency use authorization for a kit made by Abbott Laboratories.

The test, called BinaxNOW, takes just 15 minutes to produce a result, and is priced at only $5. It involves a nasal swab procedure conducted by health professionals, and a small reactive card that displays the result.

Read more
Apple preps more store reopenings ahead of new iPhone launch
Apple store Japan

Apple is preparing to open more of its retail stores that were shuttered over the summer due to the coronavirus pandemic.

The tech company has been closely monitoring the development of the COVID-19 outbreak in the U.S., reopening stores where infection cases have fallen away while closing ones where spikes have been detected. It’s a pattern that looks set to continue for some time as authorities across the country continue to battle the virus.

Read more
FDA authorizes use of blood plasma to treat COVID-19 patients
fda authorizes use of blood plasma to treat covid 19 patients convalescent

The U.S. Food and Drug Administration (FDA) has authorized the use of convalescent blood plasma in the treatment of COVID-19 patients.

The FDA's emergency use authorization (EUA) comes amid ongoing pressure from President Trump for organizations to speed up drug development and testing to fight COVID-19. Trump praised the agency's decision at a White House press conference on Sunday, August 23.

Read more